A Registry of Participants with Prostate Cancer in Asia
Not Applicable
- Conditions
- Health Condition 1: null- Prostate cancer
- Registration Number
- CTRI/2018/01/011570
- Lead Sponsor
- Janssen Research Development LLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Male aged 21 years or older - Documented diagnosis of PC with either: High-risk localized PC; Nonmetastatic, biochemically recurrent PC;
Metastatic PC - Signed participation agreement/Informed Consent Form (ICF) by the patient or a legally acceptable
representative - Agree to be followed-up for PC per routine clinical care
Exclusion Criteria
No Specific Exclusion Criteria were defined
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Overall Survival (OS) <br/ ><br>2.Prostate Cancer (PC)-related Mortality (PM) <br/ ><br>3.Metastasis-free survival (MFS) <br/ ><br>4.Progression-free Survival (PFS) <br/ ><br>5.Time to Prostate specific <br/ ><br>Antigen (PSA) Progression (TTPP) <br/ ><br>6.European Quality of Life-5 Dimensions,5 Levels (EQ-5D-5L) Score <br/ ><br>7.Functional Assessment of Cancer Therapy for Prostate Cancer (FACT-P) Score <br/ ><br>Timepoint: Up to 5 years <br/ ><br>
- Secondary Outcome Measures
Name Time Method oneTimepoint: Not Applicable